|
1.
|
Lundsgaard-Hansen P: Physiology and
pathophysiology of colloid osmotic pressure and albumin metabolism.
Curr Stud Hematol Blood Transfus. 53:1–17. 1986.PubMed/NCBI
|
|
2.
|
Prajapati KD, Sharma SS and Roy N: Current
perspectives on potential role of albumin in neuroprotection. Rev
Neurosci. 22:355–363. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Georgiou HM, Rice GE and Baker MS:
Proteomic analysis of human plasma: failure of centrifugal
ultrafiltration to remove albumin and other high molecular weight
proteins. Proteomics. 1:1503–1506. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Jiang L, He L and Fountoulakis M:
Comparison of protein precipitation methods for sample preparation
prior to proteomic analysis. J Chromatogr A. 1023:317–320. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Olver CS, Webb TL, Long LJ, Scherman H and
Prenni JE: Comparison of methods for depletion of albumin and IgG
from equine serum. Vet Clin Pathol. 39:337–345. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Kim SH, Kim UK, Lee WS, et al:
Albumin-like protein is the major protein constituent of luminal
fluid in the human endolymphatic sac. PLoS One. 6:e216562011.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Wiig H, Reed RK and Tenstad O:
Interstitial fluid pressure, composition of interstitium, and
interstitial exclusion of albumin in hypothyroid rats. Am J Physiol
Heart Circ Physiol. 278:H1627–H1639. 2000.PubMed/NCBI
|
|
8.
|
Shaklai N, Garlick RL and Bunn HF:
Nonenzymatic glycosylation of human serum albumin alters its
conformation and function. J Biol Chem. 259:3812–3817.
1984.PubMed/NCBI
|
|
9.
|
Spector AA: Fatty acid binding to plasma
albumin. J Lipid Res. 16:165–179. 1975.PubMed/NCBI
|
|
10.
|
Ashbrook JD, Spector AA, Santos EC and
Fletcher JE: Long chain fatty acid binding to human plasma albumin.
J Biol Chem. 250:2333–2338. 1975.PubMed/NCBI
|
|
11.
|
Sargent TD, Jagodzinski LL, Yang M and
Bonner J: Fine structure and evolution of the rat serum albumin
gene. Mol Cell Biol. 1:871–883. 1981.
|
|
12.
|
Gibbs PE and Dugaiczyk A: Origin of
structural domains of the serum-albumin gene family and a predicted
structure of the gene for vitamin D-binding protein. Mol Biol Evol.
4:364–379. 1987.PubMed/NCBI
|
|
13.
|
Fanali G, Ascenzi P, Bernardi G and Fasano
M: Sequence analysis of serum albumins reveals the molecular
evolution of ligand recognition properties. J Biomol Struct Dyn.
29:691–701. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Bujacz A: Structures of bovine, equine and
leporine serum albumin. Acta Crystallogr D Biol Crystallogr.
68:1278–1289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Luo Z, Shi X, Hu Q, Zhao B and Huang M:
Structural evidence of perfluorooctane sulfonate transport by human
serum albumin. Chem Res Toxicol. 25:990–992. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Curry S, Mandelkow H, Brick P and Franks
N: Crystal structure of human serum albumin complexed with fatty
acid reveals an asymmetric distribution of binding sites. Nat
Struct Biol. 5:827–835. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Sugio S, Kashima A, Mochizuki S, Noda M
and Kobayashi K: Crystal structure of human serum albumin at 2.5 A
resolution. Protein Eng. 12:439–446. 1999. View Article : Google Scholar
|
|
18.
|
Maruyama T, Katoh S, Nakajima M and
Nabetani H: Mechanism of bovine serum albumin aggregation during
ultrafiltration. Biotechnol Bioeng. 75:233–238. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Carter DC and Ho JX: Structure of serum
albumin. Adv Protein Chem. 45:153–203. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Phillips A, Shaper AG and Whincup PH:
Association between serum albumin and mortality from cardiovascular
disease, cancer, and other causes. Lancet. 2:1434–1436. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Nicholson JP, Wolmarans MR and Park GR:
The role of albumin in critical illness. Br J Anaesth. 85:599–610.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Singh-Zocchi M, Andreasen A and Zocchi G:
Osmotic pressure contribution of albumin to colloidal interactions.
Proc Natl Acad Sci USA. 96:6711–6715. 1999.PubMed/NCBI
|
|
23.
|
Stewart AJ, Blindauer CA, Berezenko S,
Sleep D and Sadler PJ: Interdomain zinc site on human albumin. Proc
Natl Acad Sci USA. 100:3701–3706. 2003. View Article : Google Scholar
|
|
24.
|
Hu W, Luo Q, Wu K, et al: The anticancer
drug cisplatin can cross-link the interdomain zinc site on human
albumin. Chem Commun (Camb). 47:6006–6008. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Vorum H: Reversible ligand binding to
human serum albumin. Theoretical and clinical aspects. Dan Med
Bull. 46:379–399. 1999.PubMed/NCBI
|
|
26.
|
Chuang VT, Kragh-Hansen U and Otagiri M:
Pharmaceutical strategies utilizing recombinant human serum
albumin. Pharm Res. 19:569–577. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Fasano M, Curry S, Terreno E, et al: The
extraordinary ligand binding properties of human serum albumin.
IUBMB Life. 57:787–796. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Buckow R, Wendorff J and Hemar Y:
Conjugation of bovine serum albumin and glucose under combined high
pressure and heat. J Agric Food Chem. 59:3915–3923. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Xiao J, Wu M, Kai G, Wang F, Cao H and Yu
X: ZnO-ZnS QDs interfacial heterostructure for drug and food
delivery application: enhancement of the binding affinities of
flavonoid aglycones to bovine serum albumin. Nanomedicine.
7:850–858. 2011. View Article : Google Scholar
|
|
30.
|
Yang M, Hoppmann S, Chen L and Cheng Z:
Human serum albumin conjugated biomolecules for cancer molecular
imaging. Curr Pharm Des. 18:1023–1031. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Zhi J, Teller SB, Satoh H, Koss-Twardy SG
and Luke DR: Influence of human serum albumin content in
formulations on the bioequivalency of interferon alfa-2a given by
subcutaneous injection in healthy male volunteers. J Clin
Pharmacol. 35:281–284. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Otsubo E and Takei T: Characterization of
the surface activity of a synthetic surfactant with albumin. Biol
Pharm Bull. 25:1519–1523. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Basrur V, Yang F, Kushimoto T, et al:
Proteomic analysis of early melanosomes: identification of novel
melanosomal proteins. J Proteome Res. 2:69–79. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Angal S and Dean PD: The effect of matrix
on the binding of albumin to immobilized Cibacron Blue. Biochem J.
167:301–303. 1977.PubMed/NCBI
|
|
35.
|
Leatherbarrow RJ and Dean PD: Studies on
the mechanism of binding of serum albumins to immobilized cibacron
blue F3G A. Biochem J. 189:27–34. 1980.PubMed/NCBI
|
|
36.
|
Metcalf EC, Crow B and Dean PD: The effect
of ligand presaturation on the interaction of serum albumins with
an immobilized Cibacron Blue 3G-A studied by affinity gel
electrophoresis. Biochem J. 199:465–472. 1981.PubMed/NCBI
|
|
37.
|
Malik A, Rudolph R and Sohling B: A novel
fusion protein system for the production of native human pepsinogen
in the bacterial periplasm. Protein Expr Purif. 47:662–671. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Girard M, Bietlot HP, Mousseau N, Cyr TD
and Ethier JC: Use of capillary electrophoresis for the
characterization of human serum albumin heterogeneity. Biomed
Chromatogr. 12:183–184. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Francis GL: Albumin and mammalian cell
culture: implications for biotechnology applications.
Cytotechnology. 62:1–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
